Warburg Cuts Chinese Pharma Firm Stake With Hefty Windfall

This Data Is Locked!

This area is available only to Subscribers.

Private equity firm Warburg Pincus has trimmed its stake in NASDAQ-listed China Biologic Products again, selling a 16% stake for US$425.7 million, according to a... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?